From Evan Harris <[email protected]>
Subject The key to stopping Biden’s healthcare plan: Gridlock
Date November 10, 2020 7:14 AM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
PRI's Focus on Health Care

View this email in your browser ([link removed])

The key to stopping Biden’s healthcare plan: Gridlock
The Washington Examiner | Sally C. Pipes
November 9, 2020

Republicans will have to stand firm against Biden’s plan to lower the Medicare eligibility age to 60 from the current 65. That proposal would bring an additional 23 million people into the program at a cost of $200 billion over the next decade. Never mind that Medicare’s Part A hospital insurance trust fund is already set to run out of money before Biden’s term ends.
Read more. . . ([link removed])

The John Batchelor Show Talks COVID-19 Mutations w/ Dr. Henry Miller
The John Batchelor Show | Henry Miller, M.S., M.D.
November 5, 2020

Henry Miller, M.S., M.D., joins the John Batchelor Show to discuss an alleged mutation of COVID-19 in Europe. Miller explains the difference between flu or cold mutations and how these mutations to mink farms could jeopardize current novel coronavirus vaccines. Several of the mutations in Denmark and the Netherlands have moved directly from animal to human, according to the Wall Street Journal.
L ([link removed]) isten here. . . ([link removed])

Biden His Time On Health Care?
Forbes.com | Sally C. Pipes
November 6, 2020

The program can barely afford its current beneficiaries, let alone a new crop. Medicare’s Part A hospital insurance trust fund will run dry in just four years, according to a report from the Congressional Budget Office. Opening the program up to those 60 and over would add 23 million people to its rolls and could require an additional $200 billion in spending over 10 years, according to the Committee for a Responsible Federal Budget.
Read more. . . ([link removed])

Dr. Henry Miller Explains Problems with Vaccines and COVID-19
The Lars Larson Show | Henry Miller, M.S., M.D.
November 3, 2020

Dr. Henry Miller, M.S., M.D. talks about the impact of a pending vaccine in the United States. Miller also talks about continuing treatments like remdisivir, zinc, and other common treatments to help fight the COVID-19 and how they will play an important role as more vaccine are developed. Larson and Miller also talk about how COVID-19 has been found to impact the immune system and what hospitals and health care officials can do to lessen the impact of the coronavirus.
L ([link removed]) isten here. . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis